1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 21-30 of 56 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Effects of intraduodenal glutamine on incretin hormone and insulin release, the glycemic response to an intraduodenal glucose infusion, and antropyloroduodenal motility in health and type 2 diabetesChang, J.; Wu, T.; Greenfield, J.; Samocha-Bonet, D.; Horowitz, M.; Rayner, C.
2021Potential for gut peptide‐based therapy in postprandial hypotensionBorg, M.J.; Xie, C.; Rayner, C.K.; Horowitz, M.; Jones, K.L.; Wu, T.
2012The effects of sitagliptin on gastric emptying in healthy humans - a randomised, controlled studyStevens, J.; Horowitz, M.; Deacon, C.; Nauck, M.; Rayner, C.; Jones, K.
2008Transient, early release of glucagon-like peptide-1 during low rates of intraduodenal glucose deliveryKuo, P.; Chaikomin, R.; Pilichiewicz, A.; O'Donovan, D.; Wishart, J.; Meyer, J.; Jones, K.; Feinle-Bisset, C.; Horowitz, M.; Rayner, C.
1999Effects of oral fructose and glucose on plasma GLP-1 and appetite in normal subjectsKong, M.F.; Chapman, I.; Goble, E.; Wishart, J.; Wittert, G.; Morris, H.; Horowitz, M.
1998Relation between gastric emptying of glucose and plasma concentrations of glucagon-like peptide-1Wishart, J.; Horowitz, M.; Morris, H.; Jones, K.; Nauck, M.
2002The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabeticsLee, A.; Patrick, P.; Wishart, J.; Horowitz, M.; Morley, J.
2007Intravenous CCK-8, but not GLP-1, suppresses ghrelin and stimulates PYY release in healthy menBrennan, I.; Otto, B.; Feltrin, K.; Meyer, J.; Horowitz, M.; Feinle-Bisset, C.
2008Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutideHorowitz, M.; Visboll, T.; Zdravkovic, M.; Hammer, M.; Madsbad, S.
2011Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetesDeane, A.; Summers, M.; Zaknic, A.; Chapman, M.; Fraser, R.; Di Bartolomeo, A.; Wishart, J.; Horowitz, M.

Discover